ARCHIVES

In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored

This article is from The Cancer Letter archive.

Vol. 23 No. 41 | October 24, 1997

Download PDF Visit The Full Archive

Related Articles

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

In Brief: NCI Registers Web Domain CANCER>GOV, Plans To Improve External Communications

October 29, 1999

Postponed Surgery For Low-Grade Prostate Cancer Adds No Risk

April 29, 2011

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

May 21, 2004

French Cancer Group Vow to Spend More On Cancer Research

January 12, 1996